The Virtual Rheumatology Program for Fellows in Training (V-FIT) is a collection of online programs developed by rheumatology experts to address specific educational needs of fellows-in-training. V-FIT includes four online courses: Virtual Rheumatology Learning Collaborative (ViRL), Virtual Rheumatology Practicum for Adult Rheumatology Fellows (ViP Adult), Virtual Rheumatology Practicum for Pediatric Rheumatology Fellows (ViP Pediatric), and Virtual Rheumatology Teaching Lessons (ViTLs). 

This activity includes online lectures on antiphospholipid syndrome. 

See full details about the activity, including target audience, CE & MOC information, and acknowledgement of commercial support, on the catalog page.

Antiphospholipid Syndrome (Doruk Erkan, MD, MPH 2023)

• Review the spectrum of Antiphospholipid Syndrome (APS).

• Discuss the diagnostic utility of anphospholipid anbody (aPL) tests.

• Discuss the management of persistently aPL-positive patients with different aPL-related clinical manifestation.

Antiphospholipid Syndrome: A 2022 Update (Yu (Ray) Zuo, MD, MS; 2022)

• Provide a brief historical perspective

• Discuss clinical manifestations and approaches to treatment

• Discuss APS and COVID-19

Antiphospholipid Syndrome (Jason Knight, MD, PhD; 2021)

• Provide a brief historical perspective

• Discuss clinical manifestations and approaches to treatment

• Discuss APS and COVID-19

Antiphospholipid Syndrome (Medha Barbhaiya, MD, MPH; 2020)

• Review the spectrum of clinical manifestations associated with antiphospholipid antibodies

• Discuss the multi-factorial nature of thrombosis associated with antiphospholipid antibodies, with acquired and inherited risk factors

• Discuss diagnosis and management of antiphospholipid syndrome

Antiphospholipid Antibody Syndrome (Sarah Goglin, MD; 2020) 

• Describe the clinical manifestations and pathogenesis of APS

• Describe the risk of thrombosis in patients with +aPL

• Compare and contrast the management of venous and arterial APS

• Describe the management of APS in pregnancy

• Apply evidence to choose the most effective anticoagulant for treatment of APS

• Evaluate a patient with features of catastrophic APS

Doruk Erkan, MD, MPH

Dr. Doruk Erkan is a Physician-Scientist at the Barbara Volcker Center for Women and Rheumatic Diseases, Attending Rheumatologist and Clinical Researcher at Hospital for Special Surgery, and Professor of Medicine at Weill Cornell Medical College. In addition to his rheumatology practice, Dr. Erkan has a long-standing research interest in Antiphospholipid Syndrome (an autoimmune clotting disorder) and Systemic Lupus Erythematosus (SLE or “lupus”). After his Internal Medicine residency at Beth Israel Medical Center in New York, he completed his Rheumatology fellowship at Hospital for Special Surgery in New York. Dr. Erkan has a medical doctor (MD) degree from Hacettepe University School of Medicine in Ankara, Turkey and a master of public health (MPH) degree from Johns Hopkins University School of Public Health in Baltimore, Maryland. Dr. Erkan has received several honors and awards from the American College of Rheumatology and the Arthritis Foundation for his research. He has published over 200 articles including research papers and invited editorials, as well as over 35 book chapters, and he has given over 170 research presentations and 200 invited lectures. He is the co-editor of two Antiphospholipid Syndrome textbooks and the Neurology volume of the Handbook of Systemic Autoimmune Disease. Dr. Erkan is also the Associate Editor of Hospital for Special Surgery’s Manual of Rheumatology and Outpatient Orthopedic Disorders.

Yu (Ray) Zuo, MD, MS

Dr. Zuo is the Edward T. and Ellen K. Dryer Early Career Professor of Rheumatology, and Assistant Professor in the Division of Rheumatology at the University of Michigan. His research focuses on the pathogenic role of neutrophil extracellular traps (NETs) and autoimmunities against NETs in various thromboinflammatory diseases such as antiphospholipid syndrome and COVID-19. He has authored some 40 papers, and his current research is supported by NIH NIAMS K08, the Arthritis National Research Foundation, the Rheumatology Research Foundation, and the Frankel Cardiovascular Center at the University of Michigan.

Jason Knight, MD, PhD

Dr. Knight is the Marvin and Betty Danto Research Professor of Rheumatology and an Associate Professor of Medicine at the University of Michigan. His laboratory studies antiphospholipid syndrome, lupus, and COVID-19.

Medha Barbhaiya, MD, MPH

Dr. Medha Barbhaiya is an Assistant Attending Physician from the Hospital for Special Surgery, and an Assistant Professor of Medicine and Healthcare Policy and Research at Weill Cornell Medical College in New York. During her rheumatology fellowship at Brigham and Women's Hospital in Boston, Dr. Barbhaiya obtained a Master's in Public Health degree from the Harvard T.H. Chan School of Public Health. She has received institutional grants as well as grants from the Rheumatology Research Foundation. Dr. Barbhaiya's research interests focus on studyingrisk factors as well as outcomes related to rheumatic diseases including systemic lupus erythematosus and antiphospholipid syndrome. She is currently involved in the international effort to develop new classification criteria for antiphospholipid syndrome. She specializes in the treatment of antiphospholipid syndrome, lupus, inflammatory arthritis, undifferentiated connective tissue disease, pregnancy, vasculitis, scleroderma, Sjogren's syndrome, and Raynaud's, along with other rheumatologic conditions.

Sarah Goglin, MD

Dr. Sarah Goglin specializes in rheumatology, with a clinical focus on the systemic vasculitides and antiphospholipid antibody syndrome. She joined UCSF in 2009 and currently practices at the Zuckerberg San Francisco General Rheumatology clinic as well as the UCSF Vasculitis Clinic, where she is the Associate Director. She attends on the inpatient rheumatology consultation service at ZSFG.

Dr. Goglin holds multiple leadership roles in medical education at UCSF. She is the Associate Chief of Education in the Division of Rheumatology at UCSF, where she oversees educational strategy and curriculum development for medical students, medicine residents, and rheumatology fellows. She is the Associate Program Director of the UCSF Rheumatology Fellowship and a Senior Associate Program Director in the UCSF Internal Medicine Residency, where she focuses on subspecialty education. She also participates in national educational activities through the American College of Rheumatology, including serving as a member of In Training Exam task force and the Education and Workforce Subcommittee of the Annual Meeting Planning Committee

This program is designed for educational purposes only. The material presented is not intended to represent the only or the best methods appropriate for the medical situations discussed, but rather is intended to present the opinions of the authors or presenters, which may be helpful to other practitioners. Attendees participating in this education activity sponsored by the ACR do so with full knowledge that they waive any claim they may have against the ACR for reliance on any information presented during this educational activity.